The stem cell market and policy options: a call for clarity
Amy Zarzeczny(University of Regina), Timothy Caulfield(University of Alberta), Harold Atkins(University of Ottawa), Judy Illes(University of British Columbia), Jeremy Snyder(Simon Fraser University), Leigh Turner(University of California, Irvine), Julie M. Robillard(University of British Columbia), Patricia J. Zettler(Georgia State University), Zubin Master(Wake Forest University), Jonathan Kimmelman(McGill University)
Cited by 22
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503
Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ <sup>18</sup> F]Fluorodeoxyglucose and [ <sup>11</sup> C]Deoxyglucose
|Journal of Cerebral Blood Flow & Metabolism|1985|419